Haleon (HLN) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Aug 2024 04:59 PM
RNS
Transaction in Own Shares
09 Aug 2024 06:07 PM
RNS
Transaction in Own Shares
08 Aug 2024 05:15 PM
RNS
Transaction in Own Shares
07 Aug 2024 05:13 PM
RNS
Transaction in Own Shares
06 Aug 2024 05:28 PM
RNS
Transaction in Own Shares
06 Aug 2024 10:00 AM
RNS
Directorate Change
05 Aug 2024 05:42 PM
RNS
Transaction in Own Shares
02 Aug 2024 06:21 PM
RNS
Transaction in Own Shares
01 Aug 2024 07:05 AM
RNS
Commencement of On-Market Share Buyback Programme
01 Aug 2024 07:00 AM
RNS
Haleon 2024 Half Year Results
26 Jun 2024 12:45 PM
RNS
Divestment of NRT business outside of the US
31 May 2024 04:47 PM
RNS
Disposal of the ChapStick brand completed
23 May 2024 05:15 PM
RNS
Director/PDMR Shareholding
20 May 2024 02:45 PM
RNS
Holding(s) in Company
20 May 2024 02:15 PM
RNS
Director/PDMR Shareholding
17 May 2024 05:30 PM
RNS
Haleon
08 May 2024 05:15 PM
RNS
Results of Haleon 2024 Annual General Meeting
07 May 2024 09:30 AM
RNS
EMTN programme: publication of base prospectus
01 May 2024 11:10 AM
RNS
Directorate Change
01 May 2024 07:00 AM
RNS
Haleon 2024 Q1 Trading Statement
24 Apr 2024 07:00 AM
RNS
Appointment of Dawn Allen as CFO
12 Apr 2024 12:00 PM
RNS
Notice of Annual General Meeting (AGM)
03 Apr 2024 11:30 AM
RNS
Director/PDMR Shareholding
02 Apr 2024 09:15 AM
RNS
Total Voting Rights and Capital
22 Mar 2024 11:30 AM
RNS
Holding(s) in Company
21 Mar 2024 06:00 PM
RNS
Haleon
21 Mar 2024 04:38 PM
RNS
Total Voting Rights and Capital
21 Mar 2024 04:05 PM
RNS
Closing of Secondary Global Offering by Pfizer
20 Mar 2024 08:39 AM
RNS
Final prospectus supplement filed with the SEC
19 Mar 2024 07:00 AM
RNS
Pricing and upsize of Secondary Global Offering
18 Mar 2024 11:00 AM
RNS
Preliminary prospectus supplement filed with SEC
18 Mar 2024 07:00 AM
RNS
Proposed Secondary Global Offering by Pfizer Inc.
15 Mar 2024 03:00 PM
RNS
Publication of Annual Report and Form 20-F 2023
14 Mar 2024 04:20 PM
RNS
Director/PDMR Shareholding
12 Mar 2024 03:30 PM
RNS
Director/PDMR Shareholding
05 Mar 2024 02:30 PM
RNS
Director/PDMR Shareholding
29 Feb 2024 07:00 AM
RNS
Haleon Preliminary 2023 Full Year Results
12 Feb 2024 04:15 PM
RNS
Director/PDMR Shareholding
02 Feb 2024 02:15 PM
RNS
Director Declaration
25 Jan 2024 07:00 AM
RNS
Haleon to sell ChapStick
18 Jan 2024 05:00 PM
RNS
Holding(s) in Company
17 Jan 2024 06:00 PM
RNS
Haleon
11 Jan 2024 01:00 PM
RNS
Director/PDMR Shareholding
19 Dec 2023 01:00 PM
RNS
Director/PDMR Shareholding
13 Dec 2023 10:30 AM
RNS
Director/PDMR Shareholding
21 Nov 2023 12:01 AM
GNW
UK falls to third place in global Health Incl...
21 Nov 2023 12:01 AM
GNW
Health exclusion affects more than three in f...
10 Nov 2023 01:00 PM
RNS
Director/PDMR Shareholding
02 Nov 2023 07:00 AM
RNS
Haleon 2023 Q3 Trading Statement
13 Oct 2023 03:30 PM
RNS
Director/PDMR Shareholding

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins.

Haleon share price launched at 317p in 2022 under the ticker HLN.

UK 100

Latest directors dealings